Characterization of JAK2V617F and the JAK2 46/1 germline haplotype in myeloproliferative neoplasms in a Saudi Arabian cohort: a case-based analysis - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Analysis of JAK2V617F Mutation and JAK2 46/1 Germline Haplotype in Myeloproliferative Neoplasms Among a Saudi Arabian Population: A Case Study Approach

  • By

  • Nouf Mutrib

  • Sana Alqarni

  • Abdul Ali Peer-Zada

  • Manar Samman

  • Sabiha Fatima

  • Sadia Arjumand

  • Hala Aldahshan

  • Khalid K. Alharbi

  • May M. AlRashed

  • September 15, 2026

Share

Original Source(s)

Characterization of JAK2V617F and the JAK2 46/1 germline haplotype in myeloproliferative neoplasms in a Saudi Arabian cohort: a case-based analysis

  • by Nouf Mutrib, Sana Alqarni, Abdul Ali Peer-Zada, Manar Samman, Sabiha Fatima, Sadia Arjumand, Hala Aldahshan, Khalid K. Alharbi, May M. AlRashed

  • September 15, 2026

Related Content

Correction to: Anatomical and surgical factors associated with postoperative hydrocephalus after central neurocytoma resection: a large single-center cohort study

Vaccinating girls, abandoning women: the financing asymmetry between HPV immunization and the cervical cancer treatment cascade in low- and middle-income countries

Correction: Stem-like CD4 T cells in tumors: an emerging framework for antitumor immunity